In QSP-IO, however, the main outputs of interest are: (1) tumor size for response status prediction, and (2) immune profiles, such as intratumoral CD8, CD4, FoxP3 T cell density, and receptor/ligand expression level, such as PD-L1 and CTLA-4, for biomarker analysis28. This evidence concerns the gene CD8A and neoplasm.